SCHEMBL4002973

SCHEMBL4002973

CCCCOC(=O)N(C(=O)N1CCNCC1)c1cc[c]cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 3/20 0.37
HRH1 P35367 3/20 0.37
SMN1; SMN2 Q16637 6/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 4/20 0.34
HPGD P15428 3/20 0.34
KMT2A Q03164 2/20 0.34
TPSAB1 Q15661 1/20 0.34
TPSD1 Q9BZJ3 1/20 0.34
TPSG1 Q9NRR2 1/20 0.34
MEN1 O00255 1/20 0.34
TACR1 P25103 1/20 0.34
NPC1 O15118 3/20 0.33
MAPT P10636 3/20 0.33
RAB9A P51151 3/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4002967 0.83 TSHR (0.36) HRH2HRH1SMN1; SMN2LMNAPOLB
SCHEMBL3760646 0.80 HPGD (0.36) ALDH1A1HPGDNPC1MAPTRAB9A
SCHEMBL3762322 0.73 GAA (0.43) POLBALDH1A1HPGDKMT2AMEN1
SCHEMBL5820669 0.72 POLB (0.63) HRH2HRH1SMN1; SMN2LMNAPOLB
SCHEMBL17017 0.72 POLB (0.63) HRH2HRH1SMN1; SMN2LMNAPOLB
SCHEMBL18760256 0.72 POLB (0.63) HRH2HRH1SMN1; SMN2LMNAPOLB
Hydrochloric Acid SCHEMBL1111003 0.71 POLB (0.61) HRH2HRH1SMN1; SMN2LMNAPOLB
Potassium SCHEMBL30906131 0.71 POLB (0.61) HRH2HRH1SMN1; SMN2LMNAPOLB
SCHEMBL4082478 0.71 POLB (0.61) HRH2HRH1SMN1; SMN2LMNAPOLB
SCHEMBL5667296 0.68 LMNA (0.57) HRH2HRH1SMN1; SMN2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071895-A1 FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 WO disclosed